v3.25.4
INCOME TAXES - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Line Items]    
Increase (decrease) in valuation allowance of net deferred tax assets $ 8,400,000  
Ownership percentage change in outstanding common stock period (in years) 3 years  
Ownership percentage in outstanding common stock (as a percent) 50.00%  
Uncertain tax position $ 0  
Unrecognized tax benefits 0 $ 0
Unrecognized tax benefits, income tax penalties and interest accrued 0 0
2021 Appropriations Act    
Income Tax Disclosure [Line Items]    
Increase (decrease) in valuation allowance of net deferred tax assets   (8,500,000)
Federal    
Income Tax Disclosure [Line Items]    
Net operating loss carryforwards 340,200,000 235,500,000
Federal contribution carryforwards 100,000 100,000
Federal | Research and Development    
Income Tax Disclosure [Line Items]    
Tax credit carryforwards 22,500,000 20,200,000
Federal | Orphan Drug Tax Credit Carry forward    
Income Tax Disclosure [Line Items]    
Tax credit carryforwards 13,500,000 13,500,000
State    
Income Tax Disclosure [Line Items]    
Net operating loss carryforwards 317,300,000 212,000,000.0
State | Research and Development    
Income Tax Disclosure [Line Items]    
Tax credit carryforwards $ 100,000 $ 100,000